These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9324171)
1. Regression of a distal bile duct carcinoma after treatment with octreotide for 6 months. Sulkowski U; Dinse P; Haus U; Collins W Digestion; 1997; 58(4):407-9. PubMed ID: 9324171 [TBL] [Abstract][Full Text] [Related]
2. Restricted cystic duct carcinoma. Miura F; Takada T; Amano H; Yoshida M Am J Surg; 2007 Jun; 193(6):738-9. PubMed ID: 17512287 [No Abstract] [Full Text] [Related]
3. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis. Pasanen PA; Partanen KP; Pikkarainen PH; Alhava EM; Janatuinen EK; Pirinen AE Eur J Surg; 1993 Jan; 159(1):23-9. PubMed ID: 8095802 [TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel. Menges M; Pees HW Int J Pancreatol; 1999 Dec; 26(3):193-9. PubMed ID: 10732297 [TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, diagnosis and survival of resected distal bile duct cancer. Zerbi A; Balzano G; Leone BE; Angeli E; Veronesi P; Di Carlo V Dig Surg; 1998; 15(5):410-6. PubMed ID: 9845623 [TBL] [Abstract][Full Text] [Related]
7. [Complications of endoscopic retrograde cholangiopancreatography during preparation of patient for pancreatoduodenal resection]. Kriger AG; Berelavichus SV; Sutiagin AG; Andreĭtsev IL Khirurgiia (Mosk); 2005; (7):55-7. PubMed ID: 16196159 [No Abstract] [Full Text] [Related]
8. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Navaneethan U; Hasan MK; Kommaraju K; Zhu X; Hebert-Magee S; Hawes RH; Vargo JJ; Varadarajulu S; Parsi MA Gastrointest Endosc; 2016 Oct; 84(4):649-55. PubMed ID: 26995690 [TBL] [Abstract][Full Text] [Related]
9. [A case of primary small cell carcinoma arising from the common bile duct]. Jeon WJ; Chae HB; Park SM; Youn SJ; Choi JW; Kim SH Korean J Gastroenterol; 2006 Dec; 48(6):438-42. PubMed ID: 17189930 [TBL] [Abstract][Full Text] [Related]
10. Clinics in diagnostic imaging (115). Extraluminal biliary tree obstruction due to compression by pancreatic head tumour. Wai CT; Seto KY; Sutedja DS Singapore Med J; 2007 Apr; 48(4):361-6; quiz 367. PubMed ID: 17384888 [TBL] [Abstract][Full Text] [Related]
11. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide]. Scheffold N; Arnold R; Cyran J Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006 [TBL] [Abstract][Full Text] [Related]
12. Tuberculous lymphadenitis as a cause of obstructive jaundice: report of a case. Obama K; Kanai M; Taki Y; Nakamoto Y; Takabayashi A Surg Today; 2003; 33(3):229-31. PubMed ID: 12658393 [TBL] [Abstract][Full Text] [Related]
14. Metachronous biliary carcinoma with intraductal pancreatic adenocarcinoma 13 years after curative resection of hilar bile duct cancer. Maekawa H; Fujikawa T; Tanaka A BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24596413 [TBL] [Abstract][Full Text] [Related]
15. Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course. Marepaily R; Micheals D; Sloan A; Hatfield J; Adsay V; Joyrich R; Ullah N; Tobi M Dig Dis Sci; 2009 Jan; 54(1):188-90. PubMed ID: 18985450 [TBL] [Abstract][Full Text] [Related]
16. Recent trends in the management of proximal bile duct cancer. Rahman QM; Nath NC; Sil B; Middya S J Indian Med Assoc; 2001 Jun; 99(6):328, 330, 334. PubMed ID: 11678622 [TBL] [Abstract][Full Text] [Related]
17. [Primary carcinoma of the cystic duct: a case report and review of the literature]. Borghese M; Gabriele R; Antoniozzi A; Teneriello F; Caporale A; Giuliani A; Lombardo F; Rengo M G Chir; 1999; 20(1-2):35-40. PubMed ID: 10097454 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma. Sulkowski U; Büchler M; Pederzoli P; Arnold R; Dinse P; Kay A; Haus U; Beger HG Eur J Cancer; 1999 Dec; 35(13):1805-8. PubMed ID: 10673995 [TBL] [Abstract][Full Text] [Related]
20. The effect of octreotide treatment on patients with pancreatic cancer who undergo endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic duct stent placement. Zheng D; Huang X; Fan Y; Liao Y; Zhang H; Wang P; Wu J Hepatogastroenterology; 2013; 60(122):222-4. PubMed ID: 22944373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]